iShares Evolved U.S. Innovative Healthcare ETF
IEIH
IEIH was delisted on the 22nd of August, 2022.
1 hedge funds and large institutions have $900K invested in iShares Evolved U.S. Innovative Healthcare ETF in 2018 Q2 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
0% more funds holding
Funds holding: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
75% less capital invested
Capital invested by funds: $3.58M → $900K (-$2.68M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
+$880K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$3.58M |
IEIH Hedge Fund Activity: Q2 2018 in Review
1 of the 4,369 institutional investors tracked by Wall St. Rank reported a position in iShares Evolved U.S. Innovative Healthcare ETF (IEIH) for Q2 2018, worth a combined $900K — down 75% from $3.58M a quarter earlier.
Fund positioning in IEIH was balanced in Q2 2018: 1 fund opened new positions, 1 closed out, 0 added to existing stakes and 0 trimmed.
The largest buyer was Virtu Financial, opening a new position worth an estimated $880K. The largest seller was BlackRock, exiting entirely with an estimated $3.58M sold.
- 1 institutional investor held iShares Evolved U.S. Innovative Healthcare ETF (IEIH) as of Q2 2018, unchanged from Q1 2018.
- Funds reported $900K of iShares Evolved U.S. Innovative Healthcare ETF stock for Q2 2018, down 75% quarter-over-quarter.
- 1 fund opened new iShares Evolved U.S. Innovative Healthcare ETF positions in Q2 2018 and 1 closed out, a net change of 0 holders.
- The largest iShares Evolved U.S. Innovative Healthcare ETF buyer in Q2 2018 was Virtu Financial, an estimated $880K added.
- The largest iShares Evolved U.S. Innovative Healthcare ETF seller in Q2 2018 was BlackRock, an estimated $3.58M sold.
Based on aggregated 13F filings for Q2 2018.